FTD Family Members Study & Post Mortem Study Alyson Negreira MGH Frontotemporal Disorders Unit.

Slides:



Advertisements
Similar presentations
APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Advertisements

Alzheimer’s Disease Edwin Onattu P. 3.
Frontotemporal Dementia
Hereditary dementia in Australian families: could there be a protective gene? William Brooks, Olivier Piguet, Hayley Bennett, G Anthony Broe Prince of.
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
Dementia with Lewy Bodies
Aging, Memory and Alzheimer’s Disease Kinga Szigeti, MD, PhD.
Small Vessel Diseases of the Brain
Human Development starts with just 1 cell – the fertilized egg. This cell divides to produce 2 ‘daughter cells’. These daughters divide, and their daughters.
Brain Scan Imaging MRI, CAT, PET Imaging
Breast Screening. NHS Breast Screening Programme Introduced in 1988 Invites women from age group for screening every 3 yrs. Age extension roll-out.
The Brain. Problems with the Brain… Dementia – group of symptoms affecting intellectual and social abilities severely enough to interfere with daily.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Assessment concepts reliability validity inter-rater test-retest construct content concurrent/descriptive predictive/criterion standardization use of consistent.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Brain Tumor. Introduction A tumor is a mass of tissue that's formed by an accumulation of abnormal cells. Normally, the cells in your body age, die, and.
Human Heredity  This section explains what scientists know about human chromosomes, as well as the inheritance of certain human traits and disorders.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Procedures Manual, Control Series, & Phenotype Committee Update Stephanie Doan, MPH NIA AD Genetics Initiative Co-Coordinator Columbia University.
Evaluation of Current Data suggests current screening does not work -high mortality rate -x-rays, sputum ineffective.
Laurence Lacoste Ph. D, Paris, France 1*. Introduction : Why ?  Population’s Ageing is a Public Health issue and dementia for the Elderly a reality 
Human Disease through Heredity. Huntington Disease Neurodegenerative Genetic Disorder that affects muscle coordination and some cognitive functions The.
Alzheimer’s Disease. Alzheimer's is a the most common form of dementia. Nearly 50-80% of all dementia patients have Alzheimer's. It is a progressive fatal.
Table of Contents What is Alzheimer's What causes Alzheimer’s What parts of the brain are affected How do you detect Alzheimer’s Alzheimer’s sample test.
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
Justin Timberlake Alicia Keys Angelina Joli David Beckham Jay-Z Gwen Stefani Paris HiltonTom Cruise
Jeremy R. Gray, Christopher F. Chabris and Todd S. Braver Elaine Chan Neural mechanisms of general fluid intelligence.
Do you remember what you ate for dinner two days ago?
CHAPTER 3 ASSESSMENT © 2013 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution.
Genetic Counselling L.O: to explain the role of a genetic counsellor Starter: What sources of information might a genetic counsellor use when examining.
Are spatial tasks useful for the early diagnosis of Alzheimer’s disease.
Center-Specific Neuropathology Procedures Survey Erin M. Pfeiffer 10/12/2002 NACC National Alzheimer’s Coordinating Center.
Compete revision sheet Allele= One member of a pair or series of genes that occupy a specific position on a specific chromosome Dominant = gene that.
Introduction of Pathology
Assessment and Diagnosis of Dementia Dr Alison Haddow.
1.
Epidemiology of Alzheimer’s Disease
GERIATRIC EDUCATION SERIES Presented in partnership by Funded in part by a grant from the EJC Foundation.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Under the supervision of miklós jászberényi
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Kimiko Domoto-Reilly, MD Cognitive / Behavioral Neurology Fellow Massachusetts General Hospital & Brigham and Women’s Hospital.
Update and Thank you to participants Bradley Hyman MD PhD Director, Mass ADRC ViceChair, Neurology, Massachusetts General Hospital.
STEM CELL RESEARCH ON HUNTINGTON’S DISEASE Josh Merrifield, Michael Jennings, and Stephanie Antone.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Biomarkers of Alzheimer’s Disease. Objectively mark Presence of neurodegenerative pathology Change in pathologic activity Purpose.
The Facts about Dementia and Other Related Conditions Developed by the: University of Wisconsin Oshkosh and Wisconsin Department of Health Services.
Revealing the Various Types of Dementia. As one advances in age, the brain becomes vulnerable to various diseases and symptoms. Most of these changes.
The National Cancer Research Network is part of the National Institute for Health Research CANCER GENETIC TRIALS Leicestershire, Northamptonshire and Rutland.
Stem Cells & Differentiation
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
Reflections on animal models of neurological disorders Marie-Francoise Chesselet UCLA
STEM CELLS USE OF STEM CELLS; MORTAL, ETHICAL OR MORAL?
AFTD Education Conference Research Update: Focus on Two Large Federally Funded Projects: LEFFTDS and ARTFL David Knopman MD Neurology Mayo Clinic Rochester.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Laura Baker, PhD Internal Medicine, Neurology, & Public Health Sciences Wake Forest School of Medicine Winston-Salem, NC USA.
The Malfunctioning Mind: Degenerative Diseases of the Brain
The study of the causes of diseases
Massachusetts General Hospital
(Draw and label a picture of a neurone here)
How Can You Study Human Heredity?
Table 2. Data Sharing for (Reporting Period)
Epilepsy in Diagnostic Imaging
Plant and Animal Biotechnology
Complete Station Race Assignment…
*****For more information, please call*****
Clinical Assessment David H. Barlow V. Mark Durand Chapter 3 p
Plant and Animal Biotechnology
Detecting and Diagnosing Alzheimer’s Disease
-supported study By Dr. Chao Peng
Presentation transcript:

FTD Family Members Study & Post Mortem Study Alyson Negreira MGH Frontotemporal Disorders Unit

Topics FTD Family Members Study Post Mortem Imaging Study

Topics FTD Family Members Study

FTD Family Members Study—Phase 1 We have begun a study that investigates the heritability, genetics, and expression of FTD in families in which a patient with FTD has 1 or more blood relatives that are/were affected by a dementia or other neurodegenerative disease (e.g., Parkinson’s, ALS, etc).. Primary goal: To identify new genes involved in the inheritance of FTD To better understand the effects of known genes on the expression of FTD To identify the earliest changes in cognitive/neurologic function in family members who were initially unaffected but who develop symptoms Procedures: Detailed review of family history NACC (National Alzheimer’s Coordinating Center) - involves an annual clinical assessment, neurologic exam, and neuropsychological assessment to measure and monitor cognitive functioning Harvard Biomarkers Study - a blood draw including testing for different genes and proteins (research, not clinical).

FTD Family Members Study FTD Family Members Study—Phase 2 We are working to add two new components to the study. Neuroimaging study: To identify changes in brain structure or function (using fMRI & PET) in individuals as the symptoms of FTD begin to develop To try to identify these changes prior to the development of symptoms Procedures would involve scans every 1-2 years in family members iPS study: Induced pluripotent stem cells… --skin biopsy (minor procedure, local anesthesia) --skin cells grown in lab, transformed into brain cells --can be investigated to identify molecular problems in that individual

FTD Family Members Study Why is this important? male female male affected by a dementia Deceased female who was affected by a dementia Family Tree Key

Family History #1 D: 57D: 89 D: 69 Dx: FTD D: 78 Dx: FTD D: 65 Dx: FTD D: 62 Dx: FTD D: 77 Dx: FTD Age: 65 Dx: FTD D: 82 D: 79 D: 74 Age: 78 Age: 73 D: 82Age: 79 Age: 40Age: 35Age: 36 male female male affected by a dementia deceased female who was affected by a dementia Family Tree Key anonymized to protect confidentiality

Topics FTD Family Members Study Questions?

Topics Post Mortem Imaging Study

MGH Brain Bank Procedures Currently: Detailed pathology analysis is performed after death We review report with family Pathology reports let families know what the underlying protein is that was causing the dementia Various types of research is done with brain tissue Why is this important? Pathology reports: In some cases, a patient can present with features of FTD, however upon autopsy they have Alzheimer’s Disease pathology

FTD Post Mortem Imaging Study Primary Goal: To better link imaging measures that can be obtained in living people to measures of brain pathology that can only be obtained after death Procedures: A series of MRI scans at higher and higher resolution (whole brain, targeted portions of brain most affected by disease) Photographs of brain sections (can be aligned with scans) Use these methods to link the two types of measures

FTD Post Mortem Imaging Study Questions?

Thank you! Thank you for your attention!